founded in 2017, has developed a proprietary machine learning-driven solution for the discovery of best-in-class and first-in-class epitope-selective immunomodulatory therapies for cancer and ...

The development of Epitope Binning-seq represents a major advancement in antibody drug discovery. By providing a rapid, comprehensive, and cost-effective method for evaluating antibody epitope ...

Therefore, identifying distinct epitope bins with functional activity ... areas that have the potential to revolutionize drug discovery. Comprised of a global community of over 12,000 life science ...

Kumamoto University researchers have identified a powerful antibody that can neutralize a wide range of SARS-CoV-2 variants, ...

OmniAb, Inc. (NASDAQ: OABI) today announced that two presentations featuring the Company's technologies were delivered at the 2024 Antibody Engineering & Therapeutics Conference (AETC) underway in San ...

Absci has achieved a breakthrough by de novo designing an antibody that targets a previously difficult-to-drug epitope in the HIV “caldera” region. This breakthrough potentially aids the development ...

The AIntibody Challenge seeks to rigorously test AI-driven antibody design and in silico predictions against experimentally validated datasets. Focusing on antibodies targeting the RBD ...

Collaboration leverages Cimeio's novel epitope shielding and immunotherapy discovery expertise -- -- Cimeio is eligible to receive an upfront payment and two years of research funding, as well ...